572 related articles for article (PubMed ID: 20808939)
21. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
[TBL] [Abstract][Full Text] [Related]
22. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
[TBL] [Abstract][Full Text] [Related]
23. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
24. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
[TBL] [Abstract][Full Text] [Related]
25. Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
Stauft CB; Yang C; Coleman JR; Boltz D; Chin C; Kushnir A; Mueller S
PLoS One; 2019; 14(10):e0223784. PubMed ID: 31609986
[TBL] [Abstract][Full Text] [Related]
26. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
[TBL] [Abstract][Full Text] [Related]
27. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.
Bosch BJ; Bodewes R; de Vries RP; Kreijtz JH; Bartelink W; van Amerongen G; Rimmelzwaan GF; de Haan CA; Osterhaus AD; Rottier PJ
J Virol; 2010 Oct; 84(19):10366-74. PubMed ID: 20686020
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.
Chen J; Zhang F; Fang F; Chang H; Chen Z
BMC Infect Dis; 2007 Oct; 7():118. PubMed ID: 17939857
[TBL] [Abstract][Full Text] [Related]
29. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
30. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
Rekstin A; Isakova-Sivak I; Petukhova G; Korenkov D; Losev I; Smolonogina T; Tretiak T; Donina S; Shcherbik S; Bousse T; Rudenko L
Biomed Res Int; 2017; 2017():9359276. PubMed ID: 28210631
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
Couch RB; Atmar RL; Keitel WA; Quarles JM; Wells J; Arden N; Niño D
Vaccine; 2012 Dec; 31(1):190-5. PubMed ID: 23107591
[TBL] [Abstract][Full Text] [Related]
33. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
34. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
Li J; Arévalo MT; Chen Y; Chen S; Zeng M
Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
[TBL] [Abstract][Full Text] [Related]
35. Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
Jones FR; Gabitzsch ES; Xu Y; Balint JP; Borisevich V; Smith J; Smith J; Peng BH; Walker A; Salazar M; Paessler S
Vaccine; 2011 Sep; 29(40):7020-6. PubMed ID: 21821082
[TBL] [Abstract][Full Text] [Related]
36. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
Lee GJ; Chu KB; Inn KS; Moon EK; Quan FS
Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021
[TBL] [Abstract][Full Text] [Related]
37. MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses.
Hessel A; Savidis-Dacho H; Coulibaly S; Portsmouth D; Kreil TR; Crowe BA; Schwendinger MG; Pilz A; Barrett PN; Falkner FG; Schäfer B
PLoS One; 2014; 9(2):e88340. PubMed ID: 24523886
[TBL] [Abstract][Full Text] [Related]
38. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.
Weaver EA; Rubrum AM; Webby RJ; Barry MA
PLoS One; 2011 Mar; 6(3):e18314. PubMed ID: 21464940
[TBL] [Abstract][Full Text] [Related]
39. Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus.
Harris K; Ream R; Gao J; Eichelberger MC
Virol J; 2011 May; 8():251. PubMed ID: 21600020
[TBL] [Abstract][Full Text] [Related]
40. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
